Every connection counts
Personalized treatments, such as cell and gene therapies, bring unprecedented challenges in manufacturing and supply chain. Those complex connections can undermine scale and success or even put patients at risk. Every point of contact, every handoff can make or break a patient journey, a reality now reflected in regulatory requirements. It’s why the Vineti solution is so essential to ensuring simplicity, safety, and control every step of the way.
In caring for my patient, I’m now performing GMP manufacturing processes. I need simplicity.
I need to ensure that we get it right. I need transparency, traceability, and powerful reporting and auditing capabilities.
I'm providing a key piece of the therapeutic process and the therapy itself. I need speed, transparency, and the best possible care.
In delivering ‘raw material’ and ‘final product,’ I’m handling living therapies. I need secure, constant collaboration and communication.
In choosing a cell or gene therapy for my patient, I'm initiating a new kind of patient journey. I need a trustworthy, straightforward process.
My shop floor revolves around the reality that each product is a 'batch of one.' I need to manage capacity and compliance, in real time.
My cell and gene therapy supply chain is now built around the patient. I need traceability, troubleshooting, and control.
My systems need to work together. I need leading software that provides seamless integration with minimal effort.
The very nature of therapeutics is changing. Every aspect of the cell and gene therapy ecosystem must now be aligned and integrated. The Vineti Personalized Therapy Management solution empowers Manufacturing, Supply Chain, Quality, IT, Commercial, and Regulatory teams with a fully transparent end-to-end platform, at any phase.
This robust, agnostic approach to ecosystem integrations enables therapy developers to connect with partners of their choice. Deploy quickly with confidence. Optimize resources. Integrate into existing workflows. All from a single platform.
The essentials of a successful personalized therapy workflow
Vineti enables full transparency into the entire personalized therapy workflow, where Chain of Identity and Chain of Custody matter more than ever. From specimen collection, to shipping, to manufacturing, Vineti's solution ensures you can watch your product reach the right patient at the right time — and step in when you need to take control. Vineti is committed to enabling and supporting the design and manufacturing of safe and effective personalized therapies through the design and development of compliant software (GAMP 5, 21 CFR Part 11) while fostering an environment of continual improvement. With multiple, successful biopharmaceutical audits in hand, Vineti is a proven compliance and regulatory partner.
Vineti provides an industry-leading approach to confidentiality and integrity of customer data. Using an advanced cloud infrastructure and a comprehensive security program, Vineti guards sensitive patient data and proprietary IP. As an enterprise software developer for the life science industry, Vineti is fully committed to compliance with key standards, including the Health Insurance Portability and Accountability Act (HIPAA) and the European Union’s General Data Protection Regulation), as well as implementation of relevant NIST cybersecurity guidelines.
Vineti maintains a comprehensive security program based on ISO 27001 to ensure the confidentiality, integrity, and availability of customer data.
Vineti's partnership program provides integrated cell and gene therapy solutions to solve for complexity in shipping, manufacturing, case management, and more. Our solution’s superior usability has earned rave reviews from a rapidly growing international network of clinical, manufacturing and other ecosystem partners. See why more and more clinical sites and industry partners are asking for Vineti when they want to offer advanced therapies simply and successfully.
Personalized therapies are advancing quickly and stakeholders expect a system that can keep pace. Advanced regulatory status may come early. Clinical phases may merge for the sake of speed and patient access. Clinical sites may join rapidly. And regulators will expect thorough data at every step on the path to approval. Vineti is the only independent software solution to have part of a successful, expedited cell therapy approval. We’re operating in more than 70 leading medical centers and growing worldwide. Patients are waiting. We’re here to help.
Join a team that's advancing what's possible
Vineti is a technology startup helping biopharmaceutical and life science companies bring life-changing medicines to people living with complex diseases. Work with the best minds in software and healthcare to innovate on our industry-leading software solution.
Kite Pharma and Vineti enter strategic partnership to develop best-in-class logistics and data analytics software for engineered T-cell therapies at commercial scale
Vineti expands its platform to support provision of American Red Cross allogeneic apheresis collections for cellular therapy
Vineti partners with World Courier to provide a state-of-the-art supply chain solution for global cell and gene therapy ecosystem
Deloitte and Vineti will team up on an end-to-end solution to support personalized medicine
Vineti and Quick Specialized Healthcare Logistics partner to share industry expertise that helps strengthen cell and gene therapy supply chains
Vineti™ to partner with Tessa Therapeutics™ to advance and scale cancer immunotherapies world-wide
Setting the standard with you in mind
Vineti is setting standards on which personalized therapies can grow. Originally founded by GE Ventures and the Mayo Clinic, Vineti is an independent company and solution-driven, hybrid team of experts. We bring backgrounds in user-centric, regulated enterprise software and analytics development, as well as commercial cell therapy development and manufacturing. From our shared experience, we know that standards matter most when they help reduce risk and optimize for growth. Uniting all of us is a belief that we are transitioning from one-size-fits-all medicine to individualized therapies as the standard of care.